Drug Shortage Report for MERSYNDOL WITH CODEINE
| Report ID | 173080 |
| Drug Identification Number | 02047667 |
| Brand name | MERSYNDOL WITH CODEINE |
| Common or Proper name | MERSYNDOL WITH CODEINE |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DOXYLAMINE SUCCINATE CODEINE PHOSPHATE ACETAMINOPHEN |
| Strength(s) | 5MG 8MG 325MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Bottle of 100 tablets |
| ATC code | N02BE |
| ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-10-24 |
| Estimated end date | 2022-11-30 |
| Actual end date | 2022-11-28 |
| Shortage status | Resolved |
| Updated date | 2022-11-30 |
| Company comments | CANADA Office of Controlled Substance License Pending approval |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-11-30 | French | Compare |
| v3 | 2022-11-30 | English | Compare |
| v2 | 2022-10-28 | French | Compare |
| v1 | 2022-10-28 | English | Compare |
Showing 1 to 4 of 4